# OnCo record temoporfin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/temoporfin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "temoporfin" ;
  schema:name "Temoporfin"@en ;
  schema:alternateName "mTHPC"@en, "meta-tetra(hydroxyphenyl)chlorin"@en, "Foscan" ;
  schema:description "Foscan is a light-activated drug used in Europe to shrink advanced head and neck cancers that have failed other treatments and cannot be operated on, irradiated or given chemotherapy, to relieve symptoms."@en ;
  schema:url <https://onco.cc/drugs/temoporfin/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Temoporfin> ;
  schema:citation <https://www.ema.europa.eu/en/medicines/human/EPAR/foscan> ;
  onco:status "approved" ;
  onco:tag "ema-list" ;
  onco:modality "Intravenous photosensitiser for photodynamic therapy" ;
  onco:approval "EU 2001: Palliative treatment of advanced head and neck squamous cell carcinoma failing prior therapy and unsuitable for radiotherapy, surgery or chemotherapy" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/> ;
  onco:companies <https://onco.cc/companies/biolitec/> ;
  onco:trials <https://onco.cc/trials/nct01415986/>, <https://onco.cc/trials/nct01086488/>, <https://onco.cc/trials/nct03003065/> .